Secretory Phospholipase A2 Enzymes as Pharmacological Targets for Treatment of Disease

Biochemical Pharmacology - Netherlands
doi 10.1016/j.bcp.2014.05.022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Evaluation of Rhamnetin as an Inhibitor of the Pharmacological Effect of Secretory Phospholipase A2

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2017English

Activity-Based Targeting of Secretory Phospholipase A2 Enzymes: A Fatty-Acid-Binding-Protein Assisted Approach

Chemistry and Physics of Lipids
BiochemistryOrganic ChemistryCell BiologyMolecular Biology
2017English

Secretory Phospholipase A2-Iia in Alzheimer's Disease and Inflammatory Responses in Astrocytes

English

Study of Association Between Genetic Polymorphisms of Phospholipase A2 Enzymes and Alzheimer's Disease

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2010English

Secretory Phospholipase A2 Tipe Ii (Spla Ii) Pada Penyakit Kardiovaskuler

Indonesian Journal of Cardiology
2015English

Akt as a Mediator of Secretory Phospholipase A2 Receptor-Involved Inducible Nitric Oxide Synthase Expression

Journal of Immunology
AllergyImmunology
2003English

Biophysical Basis for Specificity of Action of Human Isoforms of Secretory Phospholipase A2 During Cell Death

Biophysical Journal
Biophysics
2011English

Secretory Phospholipase A2-Iid Is an Effector Molecule of CD4+CD25+regulatory T Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

Total Direct Chemical Synthesis and Biological Activities of Human Group IIA Secretory Phospholipase A2

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy